Weisdorf D, Cooley S, Wang T, et al. KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation. Blood Adv. 2020;4(4):740-754.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905686/
https://www.ncbi.nlm.nih.gov/pubmed/35238913
http://dx.doi.org/10.1182/bloodadvances.2021005395
_version_ 1784665243757051904
collection PubMed
description
format Online
Article
Text
id pubmed-8905686
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-89056862022-03-09 Weisdorf D, Cooley S, Wang T, et al. KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation. Blood Adv. 2020;4(4):740-754. Blood Adv Erratum American Society of Hematology 2022-03-03 /pmc/articles/PMC8905686/ /pubmed/35238913 http://dx.doi.org/10.1182/bloodadvances.2021005395 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
spellingShingle Erratum
Weisdorf D, Cooley S, Wang T, et al. KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation. Blood Adv. 2020;4(4):740-754.
title Weisdorf D, Cooley S, Wang T, et al. KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation. Blood Adv. 2020;4(4):740-754.
title_full Weisdorf D, Cooley S, Wang T, et al. KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation. Blood Adv. 2020;4(4):740-754.
title_fullStr Weisdorf D, Cooley S, Wang T, et al. KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation. Blood Adv. 2020;4(4):740-754.
title_full_unstemmed Weisdorf D, Cooley S, Wang T, et al. KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation. Blood Adv. 2020;4(4):740-754.
title_short Weisdorf D, Cooley S, Wang T, et al. KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation. Blood Adv. 2020;4(4):740-754.
title_sort weisdorf d, cooley s, wang t, et al. kir b donors improve the outcome for aml patients given reduced intensity conditioning and unrelated donor transplantation. blood adv. 2020;4(4):740-754.
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905686/
https://www.ncbi.nlm.nih.gov/pubmed/35238913
http://dx.doi.org/10.1182/bloodadvances.2021005395

Ejemplares similares